.....a conservative $135 a share in benznidazole seem like very good crap shoots to take. I think the current stock price is undervaluing the optionality by at least 40% – meaning even at $45-50 a share KBIO is a good buy given the odds of success on benznidazole alone. At $31 the entry price to this casino is mouth-watering .......